Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial Lipodystrophy Disease (FPLD)

NCT03508687 is registered in ClinicalTrials.gov with Elif Oral as lead sponsor.

NCT NCT03508687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial Lipodystrophy Disease (FPLD)
Lead sponsor
Elif Oral
Phase
Phase 1/2
Overall status
Completed
Start date
March 13, 2018
Completion date
July 31, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial partial lipodystrophy, fatty liver, hypertriglyceridemia, nash - nonalcoholic steatohepatitis